Product NDC: | 0115-5212 |
Proprietary Name: | COLESTIPOL HYDROCHLORIDE |
Non Proprietary Name: | COLESTIPOL HYDROCHLORIDE |
Active Ingredient(s): | 5 g/1 & nbsp; COLESTIPOL HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-5212 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077277 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060502 |
Package NDC: | 0115-5212-29 |
Package Description: | 90 SUSPENSION in 1 CARTON (0115-5212-29) |
NDC Code | 0115-5212-29 |
Proprietary Name | COLESTIPOL HYDROCHLORIDE |
Package Description | 90 SUSPENSION in 1 CARTON (0115-5212-29) |
Product NDC | 0115-5212 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | COLESTIPOL HYDROCHLORIDE |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20060502 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | COLESTIPOL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | g/1 |
Pharmaceutical Classes | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |